Detalhe da pesquisa
1.
Chimpanzee Adenovirus Vector Ebola Vaccine.
N Engl J Med
; 376(10): 928-938, 2017 03 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-25426834
2.
Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection.
Proc Natl Acad Sci U S A
; 114(10): 2711-2716, 2017 03 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28223498
3.
Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials.
Lancet
; 391(10120): 552-562, 2018 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29217376
4.
Safety and pharmacokinetics of the Fc-modified HIV-1 human monoclonal antibody VRC01LS: A Phase 1 open-label clinical trial in healthy adults.
PLoS Med
; 15(1): e1002493, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29364886
5.
Safety and immunogenicity of DNA vaccines encoding Ebolavirus and Marburgvirus wild-type glycoproteins in a phase I clinical trial.
J Infect Dis
; 211(4): 549-57, 2015 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25225676
6.
Prime-boost interval matters: a randomized phase 1 study to identify the minimum interval necessary to observe the H5 DNA influenza vaccine priming effect.
J Infect Dis
; 208(3): 418-22, 2013 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23633407
7.
Phase 1 trial evaluating safety and pharmacokinetics of HIV-1 broadly neutralizing mAbs 10E8VLS and VRC07-523LS.
JCI Insight
; 9(7)2024 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38587079
8.
An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adults.
Sci Transl Med
; 15(692): eade4790, 2023 04 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37075129
9.
Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV: a phase 1, dose-escalation trial.
Nat Med
; 28(5): 1022-1030, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35411076
10.
Safety and immunogenicity of an HIV-1 prefusion-stabilized envelope trimer (Trimer 4571) vaccine in healthy adults: A first-in-human open-label, randomized, dose-escalation, phase 1 clinical trial.
EClinicalMedicine
; 48: 101477, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35783486
11.
Safety and pharmacokinetics of broadly neutralising human monoclonal antibody VRC07-523LS in healthy adults: a phase 1 dose-escalation clinical trial.
Lancet HIV
; 6(10): e667-e679, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31473167
12.
Safety and Immunogenicity of a rAd35-EnvA Prototype HIV-1 Vaccine in Combination with rAd5-EnvA in Healthy Adults (VRC 012).
PLoS One
; 11(11): e0166393, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27846256
13.
Protection against malaria at 1 year and immune correlates following PfSPZ vaccination.
Nat Med
; 22(6): 614-23, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27158907
14.
Phase I clinical evaluation of seasonal influenza hemagglutinin (HA) DNA vaccine prime followed by trivalent influenza inactivated vaccine (IIV3) boost.
Contemp Clin Trials
; 44: 112-118, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26275339
15.
Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection.
Sci Transl Med
; 7(319): 319ra206, 2015 12 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-26702094
16.
Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine.
Science
; 341(6152): 1359-65, 2013 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-23929949
17.
DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials.
Lancet Infect Dis
; 11(12): 916-24, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21975270
18.
Corrigendum: Protection against malaria at 1 year and immune correlates following PfSPZ vaccination.
Nat Med
; 22(6): 692, 2016 06 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27270781